Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TRAIL pathway refers to the signaling cascade initiated by the Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL). This pathway is primarily known for its ability to induce apoptosis selectively in tumor cells while sparing most normal cells, making it a significant target for cancer therapy.
Activation of death receptors (DR4/DR5), DISC formation, caspase activation, apoptosis induction.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRAIL Pathway.